| Dr Lori Ellen Shore, MD | |
|
2417 Central Ave, Alameda, CA 94501-4515 | |
| (510) 625-4949 | |
| Not Available |
| Full Name | Dr Lori Ellen Shore |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 28 Years |
| Location | 2417 Central Ave, Alameda, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790937506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A64852 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alta Bates Summit Medical Center | Oakland, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cornerstone Integrative Medicine | 5193142537 | 2 |
News Archive
On Friday, August 2, 2013, Jersey Shore, in partnership with Meridian Cancer Care and the Light of Life Foundation, will present a free educational conference featuring Meridian Health specialists.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
The way health care providers are paid is shifting, demanding major changes by providers. Instead of being paid for the number of patients they see and tests ordered, the system is moving toward paying providers based on patient satisfaction, good clinical outcomes and cost effectiveness.
A study published in the journal Science provides support for a new-and still controversial-understanding of the immune system. The research was conducted by collaborators in the U.S. and Europe, including Robert Cramer, PhD, an assistant professor of microbiology and immunology at the Geisel School of Medicine and member of the Dartmouth Lung Biology Center, and Kelly Shepherdson, PhD, at the time a graduate student in Cramer's lab.
Researchers from the Royal College of Surgeons in Ireland have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus could potentially benefit Irish patients who suffer from the condition.
› Verified 8 days ago
| Entity Name | Cornerstone Integrative Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881249332 PECOS PAC ID: 5193142537 Enrollment ID: O20200831000722 |
News Archive
On Friday, August 2, 2013, Jersey Shore, in partnership with Meridian Cancer Care and the Light of Life Foundation, will present a free educational conference featuring Meridian Health specialists.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
The way health care providers are paid is shifting, demanding major changes by providers. Instead of being paid for the number of patients they see and tests ordered, the system is moving toward paying providers based on patient satisfaction, good clinical outcomes and cost effectiveness.
A study published in the journal Science provides support for a new-and still controversial-understanding of the immune system. The research was conducted by collaborators in the U.S. and Europe, including Robert Cramer, PhD, an assistant professor of microbiology and immunology at the Geisel School of Medicine and member of the Dartmouth Lung Biology Center, and Kelly Shepherdson, PhD, at the time a graduate student in Cramer's lab.
Researchers from the Royal College of Surgeons in Ireland have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus could potentially benefit Irish patients who suffer from the condition.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lori Ellen Shore, MD 188 Capricorn Ave, Oakland, CA 94611-1943 Ph: (510) 594-1448 | Dr Lori Ellen Shore, MD 2417 Central Ave, Alameda, CA 94501-4515 Ph: (510) 625-4949 |
News Archive
On Friday, August 2, 2013, Jersey Shore, in partnership with Meridian Cancer Care and the Light of Life Foundation, will present a free educational conference featuring Meridian Health specialists.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
The way health care providers are paid is shifting, demanding major changes by providers. Instead of being paid for the number of patients they see and tests ordered, the system is moving toward paying providers based on patient satisfaction, good clinical outcomes and cost effectiveness.
A study published in the journal Science provides support for a new-and still controversial-understanding of the immune system. The research was conducted by collaborators in the U.S. and Europe, including Robert Cramer, PhD, an assistant professor of microbiology and immunology at the Geisel School of Medicine and member of the Dartmouth Lung Biology Center, and Kelly Shepherdson, PhD, at the time a graduate student in Cramer's lab.
Researchers from the Royal College of Surgeons in Ireland have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus could potentially benefit Irish patients who suffer from the condition.
› Verified 8 days ago
Dr. Lorraine Bonner, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2070 Clinton Ave, Rm 2113, Alameda, CA 94501 Phone: 510-814-4397 Fax: 510-814-4391 | |
Dr. William S Lowery, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2070 Clinton Ave, Alameda, CA 94501 Phone: 510-814-4089 Fax: 510-521-4187 | |
Dr. Anita C. Gaind, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2217 S Shore Ctr Ste 250, Alameda, CA 94501 Phone: 510-323-4410 Fax: 510-694-0776 | |
Dr. Alvaro Daniel Waissbluth, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2070 Clinton Ave Fl 3, Alameda, CA 94501 Phone: 510-522-6323 | |
Kinjal Patel, Internal Medicine Medicare: Medicare Enrolled Practice Location: 2217 S Shore Ctr # 250, Alameda, CA 94501 Phone: 510-323-4410 Fax: 510-694-0776 | |
David R. Craney, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2417 Central Ave, Alameda, CA 94501 Phone: 510-749-5731 | |
Dr. Catherine K Pyun, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2070 Clinton Ave, Alameda, CA 94501 Phone: 510-514-4397 Fax: 510-814-4391 |